Einstein Experts for Media

Search Results

You searched for "diabetes prevention"

3 results found

Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Department of Medicine (Endocrinology)

Jacob A. and Jeanne E. Barkey Chair in Medicine

Chief, Division of Endocrinology

Director, Fleischer Institute for Diabetes and Metabolism

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study.  read more...

 

Judith Wylie-Rosett, Ed.D.

Judith Wylie-Rosett, Ed.D.

Professor, Epidemiology & Population Health (Health Promotion and Nutrition Research)

Professor, Medicine (Endocrinology)

Division Head, Health Promotion and Nutritional Research, Department of Epidemiology & Population Health

Atran Foundation Chair in Social Medicine

NutritionObesityWeight management

Behavior modificationType 2 diabetes

Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor.  She is associate editor of the journal Diabetes Care and author of The Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements. read more...

 

Joel Zonszein, M.D.

Joel Zonszein, M.D.

Professor, Clinical Medicine (Endocrinology), Einstein

Director, Clinical Diabetes Center, Montefiore Health System

Diabetes (clinical)Type 1 diabetesType 2 diabetes

Diabetes preventionCardiovascular disease

Dr. Zonszein is an experienced clinician and researcher who focuses on preventing and treating types 1 and 2 diabetes. He has participated in landmark NIH studies, including the Diabetes Control and Complications Trial and the Diabetes Prevention Program. He has a special interest in understanding cardiovascular disease in people with diabetes and serves as the principal investigator of an ongoing NIH-sponsored study to find the best way to manage coronary artery disease in patients with type 2 diabetes.  read more...